Fig. 1From: Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxisFlow chart of participants who consulted after sexual exposure to HIV infection in one Parisian hospital between April and December 2015. PEP: HIV post-exposure prophylaxisBack to article page